Heritability and genetic linkage of left ventricular mass, systolic and diastolic function in hypertensive African Americans (from the GENOA study)

American Journal of Hypertension

Volumn 23, Issue 8, 2010, Pages 870-875

  Fox, Ervin R ^a   Klos, Kathy L ^b   Penman, Alan D ^a   Blair, George J ^a   Blossom, Benjamin D ^a   Arnett, Donna ^c   Devereux, Richard B ^d   Samdarshi, Tandaw ^a   Boerwinkle, Eric ^b   Mosley Jr , Thomas H ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

African Americans; blood pressure; echocardiography; genetics; hypertension; left ventricular mass

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHROMOSOME 12; CHROMOSOME 19; CHROMOSOME 3; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FRACTIONAL ANISOTROPY; GENETIC ANALYSIS; GENETIC LINKAGE; GENOME; GENOTYPE PHENOTYPE CORRELATION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE SEPTUM; HERITABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MITRAL VALVE; MULTICENTER STUDY; PEDIGREE; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; SIBLING; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TANDEM REPEAT; ANATOMY AND HISTOLOGY; ECHOGRAPHY; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; MIDDLE AGED; PATHOLOGY;

AFRICAN AMERICANS; AGED; COHORT STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; PEDIGREE; SYSTOLE; VENTRICULAR FUNCTION, LEFT; GENETIC LINKAGE;

EID: 77955773621     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.67     Document Type: Article

References (25)

1. Meyers KJ, Mosley TH, Fox E, Boerwinkle E, Arnett DK, Devereux RB, Kardia SL. Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacks. Hypertension 2007; 49:992-999.
2. Fox ER, Han H, Taylor HA, Walls UC, Samdarshi T, Skelton TN, Pan J, Arnett D. The prognostic value of the mitral diastolic filling velocity ratio for all-cause mortality and cardiovascular morbidity in African Americans: the Atherosclerotic Risks in Communities (ARIC) study. Am Heart J 2006; 152:749-755.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli W P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
5. Taylor HA, Penman AD, Han H, Dele-Michael A, Skelton TN, Fox ER, Benjamin EJ, Arnett DK, Mosley TH Jr. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2007; 99:1413-1420.
6. Benjamin EJ, Levy D. Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci 1999; 317:168-175.
7. FBPP Investigators. Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). Hypertension 2002; 39:3-9.
8. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129:687-702.
9. Daniels PR, Kardia SL, Hanis CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST; Genetic Epidemiology Network of Arteriopathy study. Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med 2004; 116:676-681.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
11. Kardia SL, Rozek LS, Krushkal J, Ferrell RE, Turner ST, Hutchinson R, Brown A, Sing CF, Boerwinkle E. Genome-wide linkage analyses for hypertension genes in two ethnically and geographically diverse populations. Am J Hypertens 2003; 16:154-157.
12. Yamamoto M, Wakatsuki T, Hada A, Ryo A. Use of serial analysis of gene expression (SAGE) technology. J Immunol Methods 2001; 250:45-66.
13. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62:1198-1211.
14. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30:97-101.
15. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000; 97:14478-14483.
16. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241-247.
17. Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. The genetic determination of left ventricular mass in healthy adults. Eur Heart J 2003; 24: 577-582.
18. Tang W, Arnett DK, Devereux RB, Atwood LD, Kitzman DW, Rao DC. Linkage of left ventricular early diastolic peak filling velocity to chromosome 5 in hypertensive African Americans: the HyperGEN echocardiography study. Am J Hypertens 2002; 15:621-627.
19. Tang W, Arnett DK, Devereux RB, Province MA, Atwood LD, Oberman A, Hopkins PN, Kitzman DW. Sibling resemblance for left ventricular structure, contractility, and diastolic filling. Hypertension 2002; 40:233-238.
20. Arnett DK, Devereux RB, Kitzman D, Oberman A, Hopkins P, Atwood L, Dewan A, Rao DC; Hypertension Genetic Epidemiology Network Study Group. Linkage of left ventricular contractility to chromosome 11 in humans: The HyperGEN Study. Hypertension 2001; 38:767-772. (Pubitemid 34258668)
21. Yamada M, Ikeda Y, Yano M, Yoshimura K, Nishino S, Aoyama H, Wang L, Aoki H, Matsuzaki M. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy. FASEB J 2006; 20:1197-1199.
22. Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 2000; 86:1019-1023.
23. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 2008; 153 Suppl 1: S137-S153.
24. Poornima IG, Parikh P, Shannon R P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006; 98:596-605.
25. Macera MJ, Szabo P, Wadgaonkar R, Siddiqui MA, Verma RS. Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3. Genomics 1992; 13:829-831.